{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:51:47Z","timestamp":1789588307291,"version":"build-2803163510"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Timely diagnosis and appropriate antifungal therapy are critical for improving the prognosis of patients with invasive fungal disease (IFD) after hematopoietic stem cell transplantation (HSCT). We evaluated the performance of metagenomic next-generation sequencing (mNGS) and conventional microbiological testing (CMT), as well as the diagnosis, therapeutic management, and outcomes of IFD after HSCT.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively studied 189 patients who underwent HSCT and were considered at risk for IFD. In total, 46 patients with IFD were enrolled in this study. The IFD consensus was followed for classifying IFD incidents.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Forty-six patients were diagnosed with proven\/probable (n = 12), possible (n = 27), and undefined (n = 7) IFD. <jats:italic>Aspergillus<\/jats:italic> was the most commonly detected fungal genus. <jats:italic>Mucormycosis<\/jats:italic> was found in 15 patients; two had <jats:italic>Aspergillus<\/jats:italic>, and one had <jats:italic>Candida<\/jats:italic> infections. Compared to CMT, mNGS significantly reduced the time required to identify pathogens (<jats:italic>P<\/jats:italic> = 0.0016). mNGS had a much higher sensitivity than CMT (84.78% vs. 36.96%; <jats:italic>P<\/jats:italic> &amp;lt; 0.0001). A total of 76.09% of patients received antifungal prophylaxis during fungal infections. All <jats:italic>Pneumocystis<\/jats:italic> infections occurred later than 100 days after transplantation. Among patients with <jats:italic>Pneumocystis<\/jats:italic> infection, 71.43% occurred following sulfonamide withdrawal, and subsequent treatment with sulfonamide alone or in combination with other drugs was effective. Based on the empirical antifungal treatment, the dosages, modes of administration, frequency of administration, or antifungal of 55.26% of the patients were changed according to the mNGS results. The 4-year overall survival rate of patients diagnosed with IFD after transplantation was 71.55% (95% CI, 55.18%\u201385.82%). Hypoproteinemia and corticosteroid use are independent risk factors for IFD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>mNGS, which has a high sensitivity and a short detection time, aids in the diagnosis and prognosis of pathogenic fungi. As a powerful technology, mNGS can influence treatment decisions in patients with IFD following HSCT.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2024.1210857","type":"journal-article","created":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T12:11:25Z","timestamp":1711368685000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical performance of metagenomic next-generation sequencing for diagnosis of invasive fungal disease after hematopoietic cell transplant"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiaoying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"Iii5","DOI":"10.1093\/jac\/dkt389","article-title":"Preventing invasive fungal disease in patients with haematological Malignancies and the recipients of haematopoietic stem cell transplantation: Practical aspects","author":"Akan","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cmi.2017.08.017","article-title":"Clinical use of fungal pcr from deep tissue samples in the diagnosis of invasive fungal diseases: A retrospective observational study","volume":"24","author":"Ala-Houhala","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: From the imaging working group for the revision and update of the consensus definitions of fungal disease from the eortc\/msgerc","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2018.00159","article-title":"Infection of fungi and bacteria in brain tissue from elderly persons and patients with alzheimer's disease","volume":"10","author":"Alonso","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/cid\/civ555","article-title":"Galactomannan and polymerase chain reaction-based screening for invasive aspergillosis among high-risk hematology patients: A diagnostic meta-analysis","volume":"61","author":"Arvanitis","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00216-017-0620-3","article-title":"Helicase-dependent isothermal amplification: A novel tool in the development of molecular-based analytical systems for rapid pathogen detection","volume":"410","author":"Barreda-Garc\u00eda","year":"2018","journal-title":"Anal. Bioanal Chem."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0487-y","article-title":"Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing","volume":"15","author":"Bittinger","year":"2014","journal-title":"Genome Biol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E0074622","DOI":"10.1128\/spectrum.00746-22","article-title":"Utility of metagenomic next-generation sequencing for etiological diagnosis of patients with sepsis in intensive care units","volume":"10","author":"Chien","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3760\/Cma.J.Cn112138-20200627-00624","article-title":"[The chinese guidelines for the diagnosis and treatment of invasive fungal disease in patients with hematological disorders and cancers (The 6th revision)]","volume":"59","year":"2020","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"B10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3760\/Cma.J.Issn.0253-2727.2023.02.002","article-title":"[Chinese expert consensus for invasive fungal disease in patients after hematopoietic stem cell transplantation(2023)]","volume":"44","year":"2023","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"B11","doi-asserted-by":"publisher","first-page":"E012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"Stard 2015 guidelines for reporting diagnostic accuracy studies: Explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1093\/femsre\/fuz015","article-title":"Recent trends in molecular diagnostics of yeast infections: From pcr to ngs","volume":"43","author":"Gabald\u00f3n","year":"2019","journal-title":"FEMS Microbiol. Rev."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.bbmt.2014.02.018","article-title":"Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: Revised recommendations from A consensus process by gruppo italiano trapianto midollo osseo (Gitmo)","volume":"20","author":"Girmenia","year":"2014","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1086\/509917","article-title":"Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign","volume":"44","author":"Greene","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1378\/chest.10-0488","article-title":"Accuracy of bal galactomannan in diagnosing invasive aspergillosis: A bivariate metaanalysis and systematic review","volume":"138","author":"Guo","year":"2010","journal-title":"Chest"},{"key":"B17","doi-asserted-by":"publisher","first-page":"E3876","DOI":"10.1093\/cid\/ciaa1639","article-title":"Liquid biopsy for invasive mold infections in hematopoietic cell transplant recipients with pneumonia through next-generation sequencing of microbial cell-free dna in plasma","volume":"73","author":"Hill","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/mmy\/myz109","article-title":"Long-read sequencing based clinical metagenomics for the detection and confirmation of pneumocystis jirovecii directly from clinical specimens: A paradigm shift in mycological diagnostics","volume":"58","author":"Irinyi","year":"2020","journal-title":"Med. Mycol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"E110240","DOI":"10.1371\/journal.pone.0110240","article-title":"The feasibility study of non-invasive fetal trisomy 18 and 21 detection with semiconductor sequencing platform","volume":"9","author":"Jeon","year":"2014","journal-title":"PLoS One"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.3390\/microorganisms10101882","article-title":"Next-generation sequencing applications for the study of fungal pathogens","volume":"10","author":"Jiang","year":"2022","journal-title":"Microorganisms"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients 2001-2006: Overview of the transplant-associated infection surveillance network (Transnet) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"E12981","DOI":"10.1111\/tid.12981","article-title":"Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A swiss transplant cohort study","volume":"20","author":"Kuster","year":"2018","journal-title":"Transpl Infect. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1164\/rccm.201706-1097LE","article-title":"Metagenomic sequencing detects respiratory pathogens in hematopoietic cellular transplant patients","volume":"197","author":"Langelier","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with burrows-wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.3978\/J.Issn.2072-1439.2015.12.27","article-title":"Diagnosis of pneumocystis pneumonia using serum (1-3)-\u0392-D-glucan: A bivariate meta-analysis and systematic review","volume":"7","author":"Li","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.784236","article-title":"Clinical performance of bal metagenomic next-generation sequence and serum (1,3)-\u0392-D-glucan for differential diagnosis of pneumocystis jirovecii pneumonia and pneumocystis jirovecii colonisation","volume":"11","author":"Liu","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.arcmed.2016.08.004","article-title":"Diagnosis of sepsis with cell-free dna by next-generation sequencing technology in icu patients","volume":"47","author":"Long","year":"2016","journal-title":"Arch. Med. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.2169\/internalmedicine.50.6175","article-title":"Diagnosis of invasive fungal disease using serum (1\u21923)-\u0392-D-glucan: A bivariate meta-analysis","volume":"50","author":"Lu","year":"2011","journal-title":"Intern. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1128\/JCM.06066-11","article-title":"Pcr diagnosis of pneumocystis pneumonia: A bivariate meta-analysis","volume":"49","author":"Lu","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.1093\/jac\/dkw157","article-title":"Ecil guidelines for preventing pneumocystis jirovecii pneumonia in patients with haematological Malignancies and stem cell transplant recipients","volume":"71","author":"Maertens","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1093\/cid\/ciy693","article-title":"Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice","volume":"67","author":"Miao","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/jpids\/piw066","article-title":"Neurobrucellosis: unexpected answer from metagenomic next-generation sequencing","volume":"6","author":"Mongkolrattanothai","year":"2017","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1086\/595846","article-title":"Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: Analysis of multicenter prospective antifungal therapy (Path) alliance registry","volume":"48","author":"Neofytos","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.hemonc.2017.05.013","article-title":"Complications of hematopoietic stem transplantation: fungal infections","volume":"10","author":"Omrani","year":"2017","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/j.amjmed.2011.10.008","article-title":"Invasive mycoses: diagnostic challenges","volume":"125","author":"Ostrosky-Zeichner","year":"2012","journal-title":"Am. J. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1086\/522189","article-title":"Fungal infections in recipients of hematopoietic stem cell transplants: Results of the seifem B-2004 study\u2013sorveglianza epidemiologica infezioni fungine nelle emopatie Maligne","volume":"45","author":"Pagano","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"848","DOI":"10.3390\/jof7100848","article-title":"Changing epidemiology of invasive fungal disease in allogeneic hematopoietic stem cell transplantation","volume":"7","author":"Puerta-Alcalde","year":"2021","journal-title":"J. Fungi (Basel)"},{"key":"B38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/myc.13082","article-title":"Treatment of invasive fungal diseases in cancer patients-revised 2019 recommendations of the infectious diseases working party (Agiho) of the German society of hematology and oncology (Dgho)","volume":"63","author":"Ruhnke","year":"2020","journal-title":"Mycoses"},{"key":"B39","doi-asserted-by":"publisher","first-page":"776","DOI":"10.5858\/arpa.2016-0539-RA","article-title":"Validation of metagenomic next-generation sequencing tests for universal pathogen detection","volume":"141","author":"Schlaberg","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1167\/iovs.18-26076","article-title":"The human ocular surface fungal microbiome","volume":"60","author":"Shivaji","year":"2019","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/cid\/cix881","article-title":"Understanding the promises and hurdles of metagenomic next-generation sequencing as A diagnostic tool for infectious diseases","volume":"66","author":"Simner","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"E361","DOI":"10.1016\/S2352-3026(22)00073-4","article-title":"Antifungal prophylaxis in adult patients with acute myeloid leukaemia treated with novel targeted therapies: A systematic review and expert consensus recommendation from the European hematology association","volume":"9","author":"Stemler","year":"2022","journal-title":"Lancet Haematol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"E13611","DOI":"10.1111\/tid.13611","article-title":"Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China assessment of antifungal therapy in hematological diseases (Caesar) study","volume":"23","author":"Sun","year":"2021","journal-title":"Transpl Infect. Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbmt.2015.03.018","article-title":"Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: A multicenter prospective observational study","volume":"21","author":"Sun","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B45","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"Ecil-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"B46","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/mmy\/myv092","article-title":"Clinical utility of panfungal polymerase chain reaction for the diagnosis of invasive fungal disease: A single center experience","volume":"54","author":"Trubiano","year":"2016","journal-title":"Med. Mycol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"636","DOI":"10.3390\/jof7080636","article-title":"Rapid genomic diagnosis of fungal infections in the age of next-generation sequencing","volume":"7","author":"Tsang","year":"2021","journal-title":"J. Fungi (Basel)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1016\/j.cmi.2018.01.002","article-title":"Diagnosis and management of aspergillus diseases: Executive summary of the 2017 escmid-ecmm-ers guideline","author":"Ullmann","year":"2018","journal-title":"Clin. Microbiol. Infect."},{"key":"B49","doi-asserted-by":"publisher","first-page":"E2017652","DOI":"10.1001\/jamanetworkopen.2020.17652","article-title":"Comparison of antifungal prophylaxis drugs in patients with hematological disease or undergoing hematopoietic stem cell transplantation: A systematic review and network meta-analysis","volume":"3","author":"Wang","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"Escmid-ecmm guideline: Diagnosis and management of invasive aspergillosis in neonates and children","volume":"25","author":"Warris","year":"2019","journal-title":"Clin. Microbiol. Infect."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115274","article-title":"Diagnostic value of galactomannan in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in non-neutropenic patients","volume":"99","author":"Wu","year":"2021","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"E0373022","DOI":"10.1128\/spectrum.03730-22","article-title":"A matrix-assisted laser desorption ionization-time of flight mass spectrometry direct-from-urine-specimen diagnostic for gram-negative pathogens","volume":"10","author":"Yang","year":"2022","journal-title":"Microbiol. Spectr."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1210857\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T12:23:56Z","timestamp":1711369436000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2024.1210857\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,25]]},"references-count":52,"alternative-id":["10.3389\/fcimb.2024.1210857"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2024.1210857","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,25]]},"article-number":"1210857"}}